Style | Citing Format |
---|---|
MLA | Aghsaeifard Z, Alizadeh R. "Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy." Anti-Cancer Agents in Medicinal Chemistry, vol. 23, no. 16, 2023, pp. 1811-1818. |
APA | Aghsaeifard Z, Alizadeh R (2023). Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy. Anti-Cancer Agents in Medicinal Chemistry, 23(16), 1811-1818. |
Chicago | Aghsaeifard Z, Alizadeh R. "Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy." Anti-Cancer Agents in Medicinal Chemistry 23, no. 16 (2023): 1811-1818. |
Harvard | Aghsaeifard Z, Alizadeh R (2023) 'Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy', Anti-Cancer Agents in Medicinal Chemistry, 23(16), pp. 1811-1818. |
Vancouver | Aghsaeifard Z, Alizadeh R. Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy. Anti-Cancer Agents in Medicinal Chemistry. 2023;23(16):1811-1818. |
BibTex | @article{ author = {Aghsaeifard Z and Alizadeh R}, title = {Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy}, journal = {Anti-Cancer Agents in Medicinal Chemistry}, volume = {23}, number = {16}, pages = {1811-1818}, year = {2023} } |
RIS | TY - JOUR AU - Aghsaeifard Z AU - Alizadeh R TI - Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy JO - Anti-Cancer Agents in Medicinal Chemistry VL - 23 IS - 16 SP - 1811 EP - 1818 PY - 2023 ER - |